All stock lists
Unlock the score
AIM ImmunoTech Inc. (AIM)
NYSE: AIM · Real-Time Price · USD
Healthcare · Biotechnology
0.17+0.01 (+7.49%)
Insider Score
/ 100
AIM Insider Score
AIM ImmunoTech Inc. has a live Insider Score.
Scored on 6 qualifying trades from 1 insider in the last 90 days.
AIM Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | — | 22.00 K | 21.00 K | 26.00 K | 25.00 K | 16.00 K |
| Revenue Growth (YoY) | — | 37.50 % | — | — | — | — |
| Cost of Revenue | — | 4.00 K | 40.00 K | 68.00 K | 10.00 K | 10.00 K |
| Gross Profit | — | 18.00 K | -19.00 K | -42.00 K | 15.00 K | 6.00 K |
| SG&A Expense | — | 1.76 M | 1.87 M | 1.80 M | 1.49 M | 2.54 M |
| R&D Expense | — | 482.00 K | 1.06 M | 607.00 K | 1.17 M | 1.08 M |
| Operating Expenses | — | 2.24 M | 2.93 M | 2.40 M | 2.66 M | 3.63 M |
| Operating Income | — | -2.23 M | -2.95 M | -2.45 M | -2.65 M | -3.62 M |
| Pretax Income | — | -3.02 M | -4.17 M | -3.28 M | -2.79 M | -3.71 M |
| Tax Provision | — | — | — | — | — | — |
| Net Income | — | -3.02 M | -4.17 M | -3.28 M | -2.79 M | -3.71 M |
| EPS (Basic) | -0.43 | -0.69 | — | -1.57 | -3.68 | -5.00 |
| EPS (Diluted) | -0.43 | -0.69 | — | -1.57 | -3.68 | -5.00 |
| Shares Outstanding | 17.12 M | 4.35 M | — | 2.10 M | 760.05 K | 703.30 K |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.